Ethical considerations in surveys employing respondent-driven sampling

American Journal of Public Health

Volumn 100, Issue 4, 2010, Pages 582-583

  Semaan, Salaam ^d   Heckathorn, Douglas D ^a   Des Jarlais, Don C ^b   Garfein, Richard S ^c  

^a Department of Obstetrics Gynecology   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDEMIOLOGY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL ETHICS; NOTE; PSYCHOLOGICAL ASPECT; RISK FACTOR; SUBSTANCE ABUSE;

ETHICS, MEDICAL; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; RISK FACTORS; SAMPLING STUDIES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 77949429686     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2009.184200     Document Type: Letter

References (11)

1. Dejong J, Mahfoud Z, Khouiy D, Barbir F, Afifi RA. Ethical considerations in HIV/AIDS biobbehavioral surveys that use respondent-driven sampling: illustralions from Lebanon. Am J Public Health 2009;99(9): 1562-1567.
2. Semaan S, Lauby J, Liebman J. Street and network sampling in evaluation studies of HIV risk-reduction interventions. AIDS Rev. 2002;4:213-223.
3. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines For the Protection of Human Subjecte of Research. Washington, DC: U.S. Government Printing Office; 1978. Dept of Health, Education, and Welfare Publication # OS 78-10012
4. Emanuel EJ, Wendler D, Killen J, Grady C. What makes clinical research in developing countries ethical? The benchmarks of ethical research? J Infect Dis. 2004; 189:930-937.
5. Semaan S, Santibanez S, Garfein RS, Heckathorn D, Des Jarlais DC. Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. Int J Drug Policy. 2009;20:14-27.
6. Johnston LG, Malekinejad M, Kendall C, Iuppa IM, Rutherford GW. Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: field experiences in international settings. AIDS Behau 2008;12(supp): 131-141.
7. London L. Ethical oversight of public health research: can rules and IRBs malee a difference in developing countries? Am J Public Health 2002; 92(7): 1079-1084.
8. Gahagan J, Sweeney E, Worthington C, Perry D, Satzinger F, Rogers E. Ethics issues for HIV/AIDS researchers in international settings-perspectives from the Canadian experience. Int J Infect Dis. 2008;12: 569-572.
9. Des Jarlais DC, Arasteh K, Semaan S, Wood E. HIV among injecting drug users: current epidemiology, biologie markers, respondent-driven sampling, and supervised injection facilities. Curr Opin HIV AIDS. 2009;4(4):308-313.
10. Des Jarlais DC, Semaan S. HIV prevention and psychoactive drag use: a research agenda. J Epidemiol Community Health 2009;63:191-196.
11. Heckathorn DD. Extensions of respondent-driven sampling: analyzing continuous variables and controlling for differential recruitment Sociol Methodol 2007;37: 151-208.